Company Filing History:
Years Active: 2012-2013
Title: Innovations of Jacqueline A Kirchner
Introduction
Jacqueline A Kirchner is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. With a total of 2 patents, her work has the potential to impact therapeutic approaches in medicine.
Latest Patents
Jacqueline's latest patents include groundbreaking inventions related to human GM-CSF antigen binding proteins. The first patent describes nucleic acid molecules encoding these proteins, which can inhibit the binding of GM-CSF to its receptor, GM-CSFR. This inhibition can lead to the suppression of GM-CSF-induced proliferation and signaling in myeloid lineage cell lines, as well as the activation of human monocytes. The second patent further elaborates on these antigen binding proteins, emphasizing their role in therapeutic applications.
Career Highlights
Jacqueline A Kirchner is currently associated with Amgen Inc., a leading biotechnology company. Her work at Amgen focuses on innovative solutions that address critical health challenges. Her expertise in the field has positioned her as a valuable asset to her team and the broader scientific community.
Collaborations
Jacqueline has collaborated with notable colleagues, including Kenneth Allan Brasel and Kara Olson. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological solutions.
Conclusion
Jacqueline A Kirchner's contributions to the field of biotechnology through her patents and collaborations highlight her innovative spirit and dedication to advancing medical science. Her work continues to pave the way for new therapeutic strategies that could benefit many.